Stem Cell Exosome Therapeutic Market is valued at 17.7 Million in 2024 and is predicted to reach 97.0 Million by the year 2034 at a 18.6%% CAGR during the forecast period for 2025-2034.
Exosomes are gaining popularity rapidly as a method to access the therapeutic benefits of stem cells without the complications and difficulties of delivering the cells to patients. Exosomes are sold as diagnostic devices, therapeutic agents, cosmeceuticals, research tools, and much more. The increasing prevalence of autoimmune disease, chronic inflammation, lyme disease, and other chronic degenerative diseases is expected to boost the demand for stem cell exosome therapeutic. Additionally, the emerging research activities in exosome therapeutics are likely to accelerate the market growth in upcoming years. In the last few years, the technologies related to exosomes have been mainly developed and the demand for these technologies are very useful the fields of precision medicine, liquid biopsy, and regenerative medicine. Therefore, this is further projected to enhance the adoption of stem cell exosome therapeutic. Moreover, advancements in exosome isolation and purification techniques and rising healthcare infrastructure are likely to offer lucrative growth opportunities to the global stem cell exosome therapeutic in the next few years.
The Stem Cell Exosome Therapeutics Market is a segment based on source type, application, and geography. In terms of source type, the global market is segregated into MSC, dendritic cells, umbilical MSC, plasma, and others. In 2019, the MSC or mesenchymal stem cells segment accounted for a significant share of the global stem cell exosome therapeutics market. Mesenchymal stem cells (MSCs) are one of the most commonly employed cell types as a cell-based therapy for treating human diseases. Mesenchymal stem cells are multipotent, self-renewable, easily manageable, and customarily stretchy in vitro with exceptional genomic stability. It is widely used in the treatment of degenerative and inflammatory disease offspring cells encompassing the transgene after transplantation. Mesenchymal stem cells are used to repair injured organs such as the lung, heart, and kidney. Moreover, the dendritic cells segment is anticipated to grow at the highest CAGR during the forecast period.
Based on the application, the market is segmented into precision medicine, regenerative medicine, and others. Regenerative medicine is the largest contributing category to the global stem cell exosome therapeutic market. Regenerative medicine seeks to enhance the regeneration of tissue and organs that are damaged, malfunctioning and incomplete. Stem cell therapies are promising therapeutics in this field in damaged organs such as the myocardium after heart infarction, spinal cord injury, stroke, damaged liver, and retina diseases. Mesenchymal stem cells represent a promising stem cell population for applications in regenerative medicine. Moreover, stem cell exosome therapeutic has potential applications in precision medicine.
Geographically, the global stem cell exosome therapeutic market has been segmented into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. North America dominates the global stem cell exosome therapeutic market due to the increasing number of autoimmune diseases. Additionally, the emerging research activities required for exosome therapeutics are also projected to boost the market growth. Moreover, the U.S. dominated the regional market owing to the rising preventive expenditure for healthcare and the presence of leading manufacturers of stem cell exosome therapeutics. Europe is anticipated to be the second-largest market for stem cell exosome therapeutic due to the developed healthcare sectors. Furthermore, the Asia Pacific is expected to grow at the highest CAGR with the improved healthcare services, especially in the emerging economies of Asia Pacific.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 17.7 Million |
| Revenue Forecast In 2034 | USD 97.0 Million |
| Growth Rate CAGR | CAGR of 18.6% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Source Type, By Application |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; South Korea; South East Asia |
| Competitive Landscape | Aegle Therapeutics, Brexogen, Cell Care Therapeutics, CHA Biotech Co., Ltd., ExoCoBio, Exopharm, NeoProgen, Inc., OmniSpirant, BrainStorm Cell Therapeutics Inc., Novadip Biosciences, Unicyte AG, Exogenus Therapeutics, Everkine Corporation, Creative Medical Technology Holdings, Anjarium Biosciences, Capricor Therapeutics, Inc., Kimera Labs, ReNeuron, Stem Cell Medicine Ltd., Codiak Biosciencesare |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Stem Cell Exosome Therapeutic Market Snapshot
Chapter 4. Global Stem Cell Exosome Therapeutic Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Global Stem Cell Exosome Therapeutic Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Stem Cell Exosome Therapeutic Market Industry Trends
Chapter 5. Stem Cell Exosome Therapeutic Market Segmentation 1: By Source Type, Estimates & Trend Analysis
5.1. Market Share by Source Type, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Source Type:
5.2.1. Mesenchymal Stem Cell (MSC)
5.2.2. Dendritic Cells
5.2.3. Umbilical MSC
5.2.4. Plasma
5.2.5. Others
Chapter 6. Stem Cell Exosome Therapeutic Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Precision Medicine
6.2.2. Regenerative Medicine
6.2.3. Others
Chapter 7. Stem Cell Exosome Therapeutic Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. Global Stem Cell Exosome Therapeutic Market, Regional Snapshot 2021 & 2034
7.2. North America
7.2.1. North America Stem Cell Exosome Therapeutic Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
7.2.1.1. US
7.2.1.2. Canada
7.2.2. North America Stem Cell Exosome Therapeutic Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2021-2034
7.2.3. North America Stem Cell Exosome Therapeutic Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.3. Europe
7.3.1. Europe Stem Cell Exosome Therapeutic Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
7.3.1.1. Germany
7.3.1.2. U.K.
7.3.1.3. France
7.3.1.4. Italy
7.3.1.5. Spain
7.3.1.6. Rest of Europe
7.3.2. Europe Stem Cell Exosome Therapeutic Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2021-2034
7.3.3. Europe Stem Cell Exosome Therapeutic Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.4. Asia Pacific
7.4.1. Asia Pacific Stem Cell Exosome Therapeutic Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
7.4.1.1. India
7.4.1.2. China
7.4.1.3. Japan
7.4.1.4. Australia
7.4.1.5. South Korea
7.4.1.6. Hong Kong
7.4.1.7. Southeast Asia
7.4.1.8. Rest of Asia Pacific
7.4.2. Asia Pacific Stem Cell Exosome Therapeutic Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2021-2034
7.4.3. Asia Pacific Stem Cell Exosome Therapeutic Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.5. Latin America
7.5.1. Latin America Stem Cell Exosome Therapeutic Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
7.5.1.1. Brazil
7.5.1.2. Mexico
7.5.1.3. Rest of Latin America
7.5.2. Latin America Stem Cell Exosome Therapeutic Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2021-2034
7.5.3. Latin America Stem Cell Exosome Therapeutic Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
7.6. Middle East & Africa
7.6.1. Middle East & Africa Stem Cell Exosome Therapeutic Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.6.1.1. GCC Countries
7.6.1.2. Israel
7.6.1.3. South Africa
7.6.1.4. Rest of Middle East and Africa
7.6.2. Middle East & Africa Stem Cell Exosome Therapeutic Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2021-2034
7.6.3. Middle East & Africa Stem Cell Exosome Therapeutic Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Aegle Therapeutics
8.2.2. Brexogen
8.2.3. Cell Care Therapeutics
8.2.4. CHA Biotech Co., Ltd.
8.2.5. ExoCoBio
8.2.6. OmniSpirant
8.2.7. BrainStorm Cell Therapeutics Inc.
8.2.8. Novadip Biosciences
8.2.9. Unicyte AG
8.2.10. Exogenus Therapeutics
8.2.11. Anjarium Biosciences
8.2.12. Capricor Therapeutics, Inc.
8.2.13. ReNeuron
8.2.14. Stem Cell Medicine Ltd.
8.2.15. Evox Therapeutics
8.2.16. Other Prominent Players
Global Stem Cell Exosome Therapeutic Market By Source Type
Global Stem Cell Exosome Therapeutic Market Outlook By Application
Global Stem Cell Exosome Therapeutic Market Outlook By Region
Europe Stem Cell Exosome Therapeutic Market Outlook By Country
North America Stem Cell Exosome Therapeutic Market Outlook By Country
Asia Pacific Stem Cell Exosome Therapeutic Market Outlook By Country
Latin America Stem Cell Exosome Therapeutic Market Outlook By Country
Middle East & Africa Stem Cell Exosome Therapeutic Market Outlook By Country